Company Encyclopedia
View More
name
Fibrobiologics
FBLG.US
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.
1.885 T
FBLG.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    U.S. Stock Market Movement Quick Report: Horizon Space up 62%, Aimei Health down 40%, tech stocks active

    Overview of the US Stock Market In the past hour, the US stock market has shown a significant sector rotation phenomenon. Stocks in the technology and pharmaceutical sectors have performed particularly well, with noticeable capital inflows and a sustained increase in short-term enthusiasm. Small-cap stocks and thematic stocks have experienced large fluctuations, with active market sentiment and an apparent increase in investors' risk appetite. Overall, there is a clear divergence in market strength, with a rapid switching rhythm of funds between different sectors. The stock with the largest movement, Horizon Space Acquisition I, leads the market with a 62.17% increase, attracting significant attention from short-term funds. The strong performance of this stock seems to be driven by optimistic expectations regarding its future potential, with a faster pace of capital inflow and significant volatility. Strong stocks: 1. Biodexa Pharmaceuticals: up 26.78%, the active performance of the pharmaceutical sector has driven the stock's rise, with noticeable capital inflows. 2. Polestar Automotive UK PLC - CW 27: up 18.02%, the overall recovery of the automotive sector has provided support, with active participation from short-term funds. 3. Destiny Tech100: up 14.00%, the strong performance of the technology sector has provided a favorable market environment, enhancing investor confidence. 4. Rising Dragon Acquisition: up 12.17%, with optimistic expectations for its future development, the pace of capital inflow has accelerated

    Tracking Unusual Activity·
    US
    FBLG
    +6.21%
    Tracking Unusual Activity·
    US
    FBLG
    +6.21%

    US Stock Movement Update: Horizon Space up over 55%, Aimei Health down 38%, tech stocks active

    Overview of the US Stock Market In the past hour, the US stock market has shown a clear characteristic of sector rotation, with notable performances from technology and pharmaceutical stocks. Small-cap stocks and thematic stocks have experienced significant volatility, and the flow of funds indicates a preference for short-term opportunities. Market sentiment is active, with a fast pace of fluctuations, as investors seem to be searching for quick profit opportunities. The stock with the largest movement in the past hour, Horizon Space Acquisition I, leads the market with a 55.60% increase, driven by strong capital inflows that propelled its stock price upward, creating a surge in short-term sentiment and attracting significant attention. Strong stocks: 1. Biodexa Pharmaceuticals: up 31.20%, with the active performance of the pharmaceutical sector providing strong support and noticeable capital inflows. 2. Polestar Automotive UK PLC - CW 27: up 18.02%, driven by increased enthusiasm in the automotive sector, pushing its stock price higher. 3. Rising Dragon Acquisition: up 17.39%, with optimistic expectations for its future development driving the stock price rise. 4. Destiny Tech100: up 12.93%, benefiting from the overall strength of the technology sector, providing a favorable market environment. 5. Fibrobiologics: up 11.05%, with investment enthusiasm in the biotechnology field boosting its stock price

    Tracking Unusual Activity·
    US
    FBLG
    +6.21%
    Tracking Unusual Activity·
    US
    FBLG
    +6.21%

    U.S. stock night trading volatility: Fibrobiologics surged 11.05% in after-hours trading, with active capital inflow attracting market attention

    Fibrobiologics rose 11.05% in after-hours trading; Abivax SA rose 12.15%, with a trading volume of USD 1.04 million; Recursion Pharmaceuticals fell 0.84% in after-hours trading, with a trading volume of USD 434,800; Viking Therapeutics fell 1.66% in after-hours trading, with a trading volume of USD 284,400

    Tracking Unusual Activity·
    US
    FBLG
    +6.21%
    Tracking Unusual Activity·
    US
    FBLG
    +6.21%

    FibroBiologics Repays All Outstanding Convertible Debt, Eliminates Further Dilution

    FibroBiologics Inc. has fully repaid its convertible promissory notes to YA II PN, Ltd., eliminating potential stock dilution. This strengthens the company's balance sheet, allowing focus on clinical programs. The Standby Equity Purchase Agreement with Yorkville remains, enabling up to $10 million in stock sales through December 2026. This news was generated by Public Technologies using AI and is for informational purposes only.

    Reuters·
    US
    FBLG
    +6.21%
    Reuters·
    US
    FBLG
    +6.21%

    FibroBiologics Closes $1.5 Million Registered Direct Share Offering

    05:14 PM EST, 11/25/2025 (MT Newswires) -- FibroBiologics ( FBLG ) closed a registered direct offering of 4.48 million shares at $0.335 apiece, along with related warrants, for gross proceeds of $1.5 million.Net proceeds will be used for working capital and general corporate purposes, the company said Tuesday in a statement. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

    fidelity·
    US
    FBLG
    +6.21%
    fidelity·
    US
    FBLG
    +6.21%
    © 2025 Longbridge｜Disclaimer